GLOW: Research Overview

What Is Glow Protocol?

GLOW is a peptide blend of BPC-157, TB-500 and GHK-Cu (copper peptide). Each component has been studied individually for skin, collagen or tissue-repair pathways.

Mechanism of Action

BPC-157, TB-500, and GHK-Cu work through different pathways.

Key Benefits

Combines three peptides studied in separate research on tissue repair and collagen signaling. The combination itself has not been studied.

Quick Reference

Member reference tables summarize the compound's research parameters.

Research Indications

Skin Health

Preliminary Data

Skin Rejuvenation

GHK-Cu stimulates collagen and elastin production. Combined with tissue repair peptides for comprehensive skin support.

Collagen Synthesis

GHK-Cu has demonstrated ability to increase collagen production in multiple studies. Supports skin firmness and elasticity.

Anti-Aging Support

Combination targets multiple aging pathways: collagen loss, tissue repair, and cellular regeneration.

Tissue Repair

Supported Research

Wound Healing

BPC-157 accelerates wound healing and reduces inflammation. TB-500 promotes cell migration to injury sites.

Tissue Regeneration

TB-500 supports angiogenesis and tissue remodeling. BPC-157 provides anti-inflammatory support.

Recovery Support

Each component has been studied in wound-healing and tissue-repair models. No study has tested whether the combination changes recovery outcomes.

Cellular Health

Preliminary Data

Cellular Repair

BPC-157 and TB-500 support cellular repair mechanisms. GHK-Cu modulates gene expression related to tissue remodeling.

Antioxidant Effects

GHK-Cu has demonstrated antioxidant properties, protecting cells from oxidative damage.

Research Protocols

As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.

This member section describes parameters reported in the research literature.

Peptide Interactions

This member section summarizes reported compound interactions and evidence limitations.

Reported Research Time Points

This member section summarizes reported research time points.

Safety Notes

Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.

This member section discusses research safety considerations and uncertainties.

Quality Indicators

Acceptable Range

The described verification process includes verifying Individual Peptide Content

Confirm that each peptide's labeled amount matches the supplier's certificate of analysis (COA).

Verified Marker

Blue Solution

Solution should have a light blue hue from GHK-Cu copper content (intensity varies by concentration), clear without particles

Verified Marker

Proper Labeling

Vial should clearly state individual peptide amounts, not just total weight

Research Citations

No published studies have examined the GLOW blend itself. The research below covers its individual components.

GHK-Cu

Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. https://doi.org/10.3390/ijms19071987
Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. https://doi.org/10.1155/2015/648108

BPC-157

Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. https://doi.org/10.1152/japplphysiol.00945.2010
Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125. https://doi.org/10.2174/13816128113199990421
Sikiric P, Seiwerth S, Skrtic A, et al. Stable gastric pentadecapeptide BPC 157 as a therapy and safety key: a special beneficial pleiotropic effect controlling and modulating angiogenesis and the NO-system. Pharmaceuticals (Basel). 2025;18(6):928. https://doi.org/10.3390/ph18060928

TB-500 (research on the parent molecule, thymosin beta-4)

Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. https://doi.org/10.1046/j.1523-1747.1999.00708.x
Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. https://doi.org/10.1517/14712598.2012.634793

GLOW Research Overview (also known as Regenerative Blend)

At a glance